Sample,Glycolysis scores,OXPHOS scores,FAO scores,HIF-1 scores
Patient_1_Pre_untreated,0.560322448503082,1.24261465307989,-0.71515462220238,-0.102655230434604
Patient_1_Prog_Treated_with_dabrafenib,0.513123508055552,1.18781817199893,-0.272261956939574,-0.0931382607625067
Patient_2_Pre_untreated,0.642860717059882,1.05182476181959,-0.274875069389612,-0.121850863873271
Patient_2_Prog_Treated_with_dabrafenib,0.651870097459556,0.9971687244629,-0.283473832481845,-0.135208273484631
Patient_3_Pre_untreated,0.648540347827496,0.914835741066369,-0.0670269743244966,-0.11888537776501
Patient_3_Prog_1_Treated_with_dabrafenib,0.602115000342002,0.960630679639286,-0.571765737329417,-0.0962399967168712
Patient_3_Prog_2_Treated_with_dabrafenib,0.7486671768508,1.28689681934575,-0.154125871750571,-0.0610809701645668
Patient_4_Pre_untreated,0.779897155763701,1.04095082302541,-0.459098982543131,-0.098039972093405
Patient_4_Prog_Treated_with_dabrafenib,0.722624428085415,1.01619266934402,-0.0722501211100567,-0.105751220913531
Patient_5_Pre_untreated,0.658492259256661,1.24511335141655,0.060772255334206,-0.0896056141502853
Patient_5_EDT_treated_with_dabrafenib,0.60825115053692,1.09988985568499,0.187000510658739,-0.0804621003816637
Patient_5_Prog_Treated_with_dabrafenib,0.638509737272992,1.27808739812747,-0.59190822563578,-0.0809726269134485
Patient_7_Pre_untreated,0.709339318393186,1.1365040631542,-0.326145747925836,-0.0683383264250831
Patient_7_Pre_untreated__replicate_,0.629266291919612,1.28849868349363,-0.192374886102379,-0.128906307711249
Patient_7_Prog_Treated_with_dabrafenib,0.730316005906624,1.23084581993159,0.178883085912635,-0.0911363729634342
Patient_8_Pre_untreated,0.750864048734634,1.10069083919984,0.194625069627134,-0.125536175975705
Patient_8_Pre_untreated__replicate_,0.695792707398588,1.14383157752963,-0.116110777301943,-0.135458612057291
Patient_8_Prog_1_Treated_with_dabrafenib,0.75727497076134,1.1213761046232,-0.23940103065982,-0.119871137193746
Patient_8_Prog_2_Treated_with_dabrafenib,0.766838869825345,1.00474606517811,0.120352737498658,-0.100948824229491
Patient_9_Pre_untreated,0.684171836061327,1.1948827133469,0.206077748018387,-0.144416629047482
Patient_9_Prog_Treated_with_dabrafenib,0.661751138565819,1.16656356486165,0.25996900043191,-0.119212049082776
Patient_10_Pre_untreated,0.742810634429357,1.20863830038381,-0.442762981295712,-0.140526121393688
Patient_10_Pre_untreated__replicate_,0.666277471614838,1.21554134937431,-0.118089791602137,-0.122422128288259
Patient_10_EDT_Treated_with_dabrafenib,0.758854483125298,1.21496101740793,0.355872064511195,-0.11844790084951
Patient_10_Prog_1_Treated_with_dabrafenib,0.630634963339249,1.24879359256764,0.536068606585727,-0.137143677925062
Patient_10_Prog_2_Treated_with_dabrafenib,0.66410358458061,1.21234202490146,0.20879861355192,-0.0983764927976362
Patient_11_Pre_untreated,0.527513498785198,0.92383459839182,0.293842988846291,-0.115256699634752
Patient_11_Pre_untreated__replicate_,0.575669290160878,0.959718122088344,0.146265487821909,-0.135182008454057
Patient_11_Prog_1_Treated_with_dabrafenib,0.709602770598879,0.959713709801133,0.136576079084313,-0.12413427996881
Patient_11_Prog_2_Treated_with_dabrafenib,0.539592190837497,1.14419900090922,0.50291222656705,-0.0999860467025075
Patient_11_Prog_1_Treated_with_dabrafenib__replicate_,0.64304826038621,0.905214988243798,-0.0363474675316018,-0.130822834160955
Patient_11_Prog_2_Treated_with_dabrafenib__replicate_,0.590073282716088,1.10971863367125,0.0131009516107956,-0.0967948454877499
Patient_12_Pre_untreated,0.700739557840125,1.02872729528822,0.0475360570912033,-0.115466819879345
Patient_12_Prog_Treated_with_dabrafenib,0.769008439681271,1.16668025755812,0.0326838916748236,-0.0999614232363443
Patient_13_Pre_untreated,0.776884314157994,1.10363589883712,0.0961984750435141,-0.125170927894283
Patient_13_Pre_untreated__replicate_,0.83101619802954,1.08576169729688,0.479074685203526,-0.119611770016826
Patient_13_Prog_Treated_with_dabrafenib,0.788750169847971,1.03650770776353,0.204345516299846,-0.149426683629499
Patient_14_Pre_untreated,0.768475229525245,1.28475324298987,-0.105265670854142,-0.104132638404399
Patient_14_Prog_Treated_with_dabrafenib,0.706082253233999,1.24671153727484,0.553874268028685,-0.0677317683752616
Patient_17_Pre_untreated,0.793266850454276,1.11558183476458,0.244259884269349,-0.120462921163869
Patient_17_Prog_Treated_with_dabrafenib,0.766720761768782,0.958053461741526,0.0987856220472941,-0.112900233922929
Patient_18_Pre_untreated,0.778441215042232,1.18934514911356,0.0450272470304422,-0.100080436656133
Patient_18_Pre_untreated__replicate_,0.713560575954654,1.14862899186654,-0.0438953659808826,-0.116917142036361
Patient_18_Prog_1_Treated_with_dabrafenib,0.67748599208916,1.47884706401826,0.0986546731655598,-0.119116838346945
Patient_18_Prog_2_Treated_with_dabrafenib,0.770497288679432,1.11774525246292,-0.0294703092633955,-0.106383223211721
Patient_21_Pre_untreated,0.808240893790024,1.07697390554982,0.108350390998667,-0.12382812820618
Patient_21_Prog_Treated_with_dabrafenib,0.836457636272455,1.14038713700358,0.338224592579337,-0.0984823737021381
Patient_23_Pre_untreated,0.746211142314665,1.40192813496009,-0.0686258866006226,-0.120957032051545
Patient_23_Prog_Treated_with_vemurafenib,0.7459969231001,1.09910312319017,-0.300994512687016,-0.108999056100464
Patient_24_Pre_untreated,0.854829242685635,1.03977323514045,-0.269740658473107,-0.0986424262321993
Patient_24_Pre_untreated__replicate_,0.766087736766973,1.06055513197725,-0.061637175767556,-0.09631222555095
Patient_24_Prog_Treated_with_vemurafenib,0.628670278684931,0.983661959278063,-0.371549761057658,-0.106395534944802
Patient_25_Pre_untreated,0.646622068050438,1.16991893348871,0.0289062772976579,-0.0635662986826445
Patient_25_Prog_Treated_with_vemurafenib,0.775918982832032,1.4523152977011,-0.10952637966385,-0.0598243526080354
Patient_28_Pre_untreated,0.570943425142511,1.15341082053597,0.024964028312839,-0.100971806131243
Patient_28_Prog_1_Treated_with_vemurafenib,0.595056310492347,1.35339446589392,0.0555865872622859,-0.107172815693356
Patient_28_Prog_2_Treated_with_vemurafenib,0.66840621599721,1.48847678043117,-0.000842906330107799,-0.06081749907662
Patient_28_Prog_3_Treated_with_vemurafenib,0.697941110151389,1.27859411053089,0.18357799422867,-0.103686132884639
Patient_28_Prog_4_Treated_with_vemurafenib,0.593205768288177,1.14779311415469,0.267165867091259,-0.0942331842245661
Patient_30_Pre_untreated,0.7273095686021,1.07517322905649,0.0225318037693719,-0.0978183608979357
Patient_30_Prog_Treated_with_vemurafenib,0.488476780431175,1.17288335398461,-0.0361425846506104,-0.129829687692371
